Label: SILATRIX ORAL- sucralfate gel

  • Category: MEDICAL DEVICE
  • DEA Schedule: None
  • Marketing Status: Premarket Notification

Drug Label Information

Updated January 24, 2022

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    SILATRIX ORAL GEL
    SA3, LLC

    -----------------------------

    SILATRIX ORAL GEL
    Rx only

    For oral mucosa area only

    Not for ophthalmic use

  • DESCRIPTION

    SILATRIX ORAL GEL is an amorphous hydrogel formed by the controlled reaction of sucralfate with a limited quantity of malic acid and calcium carbonate solution. The amorphous hydrogel formed by this reaction binds reversibly to wounds and is intended to form a protective film that covers wounds, protects against further irritation and relieves pain.

    Silatrix Oral Gel may be administered directly to an accessible oral wound to provide an adherent physical covering of the wound bed. Although prepared by reaction of sucralfate with an acid, the polymerized sucralfate self-buffers to a pH 5.0 - 7 .0.

  • INGREDIENTS

    SILATRIX ORAL GEL contains sucralfate, malic acid, calcium carbonate, calcium sulfate dihydrate, sucralose, xanthan gum, propylene glycol, and purified water.

  • INDICATIONS AND USES


    SILATRIX ORAL GEL
     forms a protective layer over the oral mucosa by adhering to the mucosal surface which allows it to protect against further irritation and relieve pain. The oral gel may be used in the management of mouth lesions including aphthous ulcer, stomatitis, mucositis, minor lesions, chafing and traumatic ulcers, abrasions caused by braces and ill-fitting dentures, and lesions associated with oral surgery.

  • CONTRAINDICATIONS

    SILATRIX ORAL GEL is contraindicated in patients with known serious hypersensitivity to sucralfate or any of the listed ingredients.

  • WARNINGS

    For oral mucosa area only. Avoid direct contact with eyes.

    KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN.

  • PRECAUTIONS


    Stop use and ask a doctor if irritation develops. SILATRIX ORAL GEL has no known serious side effects or adverse reactions. This medication should be used as directed by your physician during pregnancy or while breastfeeding. Consult your doctor about the risks and benefits.

    CAUTION: Federal law restricts this device to sale by or on the order of a physician or other practitioner licensed by the law of the State in which the practitioner practices to use or order the use of the device.

  • DOSAGE AND ADMINISTRATION

    Apply to mucosal wounds 2 to 3 times daily.

  • HOW SILATRIX ORAL GEL IS SUPPLIED

    SILATRIX ORAL GEL is supplied in:
    10 gram (0.35 oz) tube
    NDC: 69420-8351-1

  • STORAGE:

    Store at 20°-25°C (68° to 77°F); Keep away from heat and protect from freezing. [See USP Controlled Room Temperature.]

    MANUFACTURED FOR: 
    SA3, LLC
    Los Angeles, CA 90064

  • PRINCIPAL DISPLAY PANEL

    Silatrix Oral Gel
    Polymerized Sucralfate Gel 10%
    (1 gm/10 gm)
    10 gram (0.35 oz)
    NDC: 69420-8351-1

    Silatrix Oral Gel
Polymerized Sucralfate Gel 10%
(1 gm/10 gm)
10 gram (0.35 oz)
NDC: 69420-8351-1

  • INGREDIENTS AND APPEARANCE
    SILATRIX ORAL 
    oral wound dressing gel
    Product Information
    Product TypeMEDICAL DEVICEItem Code (Source)NHRIC:69420-8351
    Route of AdministrationORAL
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NHRIC:69420-8351-110 in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Premarket NotificationK20200002/17/2021
    Labeler - SA3, LLC (079627454)